Wordt geladen...
RTHP-32. PHASE II STUDY OF HYPO-FRACTIONATED ACCELERATED RADIOTHERAPY WITH CONCURRENT AND MAINTENANCE TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA: COMPLIANCE AND EARLY CLINICAL OUTCOME (HyART)
INTRODUCTION: To compare hypo-fractionated (HyRT) with conventional fractionated radiotherapy (CRT) for good prognosis newly diagnosed patients with glioblastoma (GBM). METHODS: HyART, a Phase II trial randomly assigned newly diagnosed GBM patients 1:1 by computer generated randomization chart to Hy...
Bewaard in:
Gepubliceerd in: | Neuro Oncol |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Oxford University Press
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692008/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.914 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|